Voorbeelden van het gebruik van Dose adjustment should in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
In consequence, dose adjustment should not.
The dose adjustment should be based on the clinical response of the individual patient.
If it occurs, appropriate dose adjustment should be made as provided.
Dose adjustment should be based on the clinical response of individual patients.
If it occurs, appropriate dose adjustment should be made as provided.
Dose adjustment should be considered based on the patient's clinical response to methadone therapy.
If it occurs, appropriate dose adjustment should be made as provided.
However, dose adjustment should be considered in patients with severe hepatic impairment
The use of other central nervous system depressants is expected to potentiate the effects of dexmedetomidine and therefore an appropriate dose adjustment should be made.
This dose adjustment should be based on FXIII activity levels.
effects of dexmedetomidine and therefore an appropriate dose adjustment should be made.
An interruption of dosing or dose adjustment should be considered see section 4.8.
The use of other central nervous system depressants is expected to potentiate the effects of dexmedetomidine and therefore an appropriate dose adjustment should be made by the veterinary surgeon.
In consequence, dose adjustment should not be made more frequently than once a month,
In patients at increased risk of symptomatic hypotension, initiation of therapy and dose adjustment should be closely monitored see 4.2“ Posology
Additional dose adjustment should normally be performed in 25 micrograms/ hour increments,
In general, any dose adjustment should be administered only after a careful benefit-risk assessment.
The effect of this dose adjustment should not be anticipated earlier than 3 weeks after the first injection with the higher dose. .
During a treatment cycle, dose adjustment should be performed for each individual medicinal product that is considered to be causally related to the toxicity, if such a distinction can be made.
The amount of dose adjustment should factor in the amount of dietary protein that has not been covered,
Patients should be closely monitored and dose adjustments should be considered if muscle symptoms develop.
Dose adjustments should be based on serum IGF-I levels.
If it occurs, appropriate dose adjustments should be made as provided.
Dose adjustments should be based on creatinine clearance values as obtained from a reliable method 24 h urine sampling.
Further dose adjustments should be done based on the clinical response
Dose adjustments should be made carefully,
Dose adjustments should be made carefully,
Subsequent dose adjustments should be based on individual safety
Dose adjustments should be based on periodic glycosylated haemoglobin(HbA1c) measurements.
Dose adjustments should be tailored to the individual patient's response and therapeutic goals maintenance